FIBROGEN INC — Director's Dealing 2023

Jul 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-07-11

Reporting Person: Henderson Jeffrey William (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-11	Common Stock	S	2000	$2.69	Disposed	32866	Direct

Footnotes

F1: Shares sold by the reporting person pursuant to a 10b5-1 trading plan.

F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.66 to $2.735. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.